The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Serial Analysis of Gene Expression
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995) · Science · doi:10.1126/science.270.5235.484 · Cited by 3,711
Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., & Paul, C. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.5.1827 · Cited by 3,238
Mutations in the p53 gene occur in diverse human tumour types
Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hosteller, R., Cleary, K., Signer, S. H., Davidson, N., Baylin, S., Devilee, P., et al. (1989) · Nature · doi:10.1038/342705a0 · Cited by 2,733
Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R., & Talpaz, M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441402 · Cited by 2,713
Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., & Bruchez, M. P. (2003) · Nature Biotechnology · doi:10.1038/nbt764 · Cited by 2,506
A molecular signature of metastasis in primary solid tumors
Ramaswamy, S., Ross, K. N., Lander, E. S., & Golub, T. R. (2003) · Nature Genetics · doi:10.1038/ng1060 · Cited by 2,449
Nanoparticle-Based Bio-Bar Codes for the Ultrasensitive Detection of Proteins
Nam, J.-M., Thaxton, C. S., & Mirkin, C. A. (2003) · Science · doi:10.1126/science.1088755 · Cited by 2,390
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Nanoparticle-Based Bio-Barcodes for the Ultrasensitive Detection of Proteins*
Nam, J.-M., Thaxton, C. S., & Mirkin, C. A. (2020) · Spherical Nucleic Acids · doi:10.1201/9781003056713-94 · Cited by 2,035
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Sotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
Molecular classification of cutaneous malignant melanoma by gene expression profiling
Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., Radmacher, M., Simon, R., Yakhini, Z., Ben-Dor, A., et al. (2000) · Nature · doi:10.1038/35020115 · Cited by 1,990
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
(1977) · PubMed · Cited by 1,801
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Self-assembled nanoscale biosensors based on quantum dot FRET donors
Medintz, I. L., Clapp, A. R., Mattoussi, H., Goldman, E. R., Fisher, B., & Mauro, J. M. (2003) · Nature Materials · doi:10.1038/nmat961 · Cited by 1,601
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Diversity of gene expression in adenocarcinoma of the lung
Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241500798 · Cited by 1,298
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., et al. (1997) · Science · doi:10.1126/science.275.5298.343 · Cited by 1,183
Self-citationHaplotype tagging for the identification of common disease genes
Johnson, G. C. L., Esposito, L., Barratt, B. J., Smith, A. N., Heward, J., Di Genova, G., Ueda, H., Cordell, H. J., Eaves, I. A., Dudbridge, F., et al. (2001) · Nature Genetics · doi:10.1038/ng1001-233 · Cited by 1,174
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
Singletary, S. E., Allred, C., Ashley, P., Bassett, L. W., Berry, D., Bland, K. I., Borgen, P. I., Clark, G., Edge, S. B., Hayes, D. F., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.026 · Cited by 1,173
Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Circulating Tumor Cells in Patients with Breast Cancer Dormancy
Meng, S., Tripathy, D., Frenkel, E. P., Shete, S., Naftalis, E. Z., Huth, J. F., Beitsch, P. D., Leitch, M., Hoover, S., Euhus, D., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1110 · Cited by 971
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Paweletz, C. P., Charboneau, L., Bichsel, V. E., Simone, N. L., Chen, T., Gillespie, J. W., Emmert-Buck, M. R., Roth, M. J., Petricoin III, E. F., & Liotta, L. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204265 · Cited by 956
Proteomic applications for the early detection of cancer
Wulfkuhle, J. D., Liotta, L. A., & Petricoin, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1043 · Cited by 907
Predicting lung cancer by detecting aberrant promoter methylation in sputum.
Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (2000) · PubMed · Cited by 891
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Chang, J. C., Wooten, E. C., Tsimelzon, A., Hilsenbeck, S. G., Gutierrez, M. C., Elledge, R., Mohsin, S., Osborne, C. K., Chamness, G. C., Allred, D. C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14023-8 · Cited by 875
Immuno-PCR: Very Sensitive Antigen Detection by Means of Specific Antibody-DNA Conjugates
Sano, T., Smith, C. L., & Cantor, C. R. (1992) · Science · doi:10.1126/science.1439758 · Cited by 861
Somatic mutations of the mitochondrial genome in human colorectal tumours
Polyak, K., Li, Y., Zhu, H., Lengauer, C., Willson, J. K. V., Markowitz, S. D., Trush, M. A., Kinzler, K. W., & Vogelstein, B. (1998) · Nature Genetics · doi:10.1038/3108 · Cited by 835
Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829
Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids
Fliss, M. S., Usadel, H., Caballero, O. L., Wu, L., Buta, M. R., Eleff, S. M., Jen, J., & Sidransky, D. (2000) · Science · doi:10.1126/science.287.5460.2017 · Cited by 820
Molecular Assessment of Histopathological Staging in Squamous-Cell Carcinoma of the Head and Neck
Brennan, J. A., Mao, L., Hruban, R. H., Boyle, J. O., Eby, Y. J., Koch, W. M., Goodman, S. N., & Sidransky, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502163320704 · Cited by 749
Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
Boshoff, C., Schulz, T. F., Kennedy, M. M., Graham, A. K., Fisher, C., Thomas, A., McGee, J. O., Weiss, R. A., & O'Leary, J. J. (1995) · Nature Medicine · doi:10.1038/nm1295-1274 · Cited by 681
Emerging molecular markers of cancer
Sidransky, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc755 · Cited by 662
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Clinical proteomics: translating benchside promise into bedside reality
Petricoin, E. F., Zoon, K. C., Kohn, E. C., Barrett, J. C., & Liotta, L. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd891 · Cited by 550
In vivo detection and imaging of phosphatidylserine expression during programmed cell death
Blankenberg, F. G., Katsikis, P. D., Tait, J. F., Davis, R. E., Naumovski, L., Ohtsuki, K., Kopiwoda, S., Abrams, M. J., Darkes, M., Robbins, R. C., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6349 · Cited by 536
Reconstruction of cellular signalling networks and analysis of their properties
Papin, J. A., Hunter, T., Palsson, B. O., & Subramaniam, S. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1570 · Cited by 532
Rules of evidence for cancer molecular-marker discovery and validation
Ransohoff, D. F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1322 · Cited by 498
Lab-on-a-chip for drug development
Weigl, B. H., Bardell, R. L., & Cabrera, C. R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00223-5 · Cited by 481
Nishizuka, S., Charboneau, L., Young, L., Major, S., Reinhold, W. C., Waltham, M., Kouros-Mehr, H., Bussey, K. J., Lee, J. K., Espina, V., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331323100 · Cited by 474
Self-citationERBB2 oncogene in human breast cancer and its clinical significance
Révillion, F., Bonneterre, J., & Peyrat, J. P. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)10157-5 · Cited by 448
BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients
Petrij-Bosch, A., Peelen, T., van Vliet, M., Eijk, R. V., Olmer, R., Drüsedau, M., Hogervorst, F. B. L., Hageman, S., Arts, P. J. W., Ligtenberg, M. J. L., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-341 · Cited by 432
Rosas, S. L. B., Koch, W. M., Carvalho, M. D. G., Wu, L., Califano, J. A., Westra, W. H., Jen, J., & Sidransky, D. (2001) · PubMed · Cited by 409
Clinical Role of FDG PET in Evaluation of Cancer Patients
Kostakoglu, L., Agress, H., & Goldsmith, S. J. (2003) · RadioGraphics · doi:10.1148/rg.232025705 · Cited by 402
Zhou, G., Li, H., DeCamp, D., Chen, S., Shu, H., Gong, Y., Flaig, M., Gillespie, J. W., Hu, N., Taylor, P. R., et al. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m100015-mcp200 · Cited by 388
Rosell, R., Danenberg, K. D., Alberola, V., Bepler, G., Sanchez, J. J., Camps, C., Provencio, M., Isla, D., Taron, M., Diz, P., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0156 · Cited by 352
Newman, B. (1998) · JAMA · doi:10.1001/jama.279.12.915 · Cited by 345
Ahrendt, S. A., Chow, J. T., Xu, L.-H., Yang, S. C., Eisenberger, C. F., Esteller, M., Herman, J. G., Wu, L., Decker, P. A., Jen, J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.4.332 · Cited by 345
Preferential response of cancer cells to zebularine
Cheng, J. C., Yoo, C. B., Weisenberger, D. J., Chuang, J., Wozniak, C., Liang, G., Marquez, V. E., Greer, S., Orntoft, T. F., Thykjaer, T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.023 · Cited by 319
Robson, M. E., Chappuis, P. O., Satagopan, J., Wong, N., Boyd, J., Goffin, J. R., Hudis, C., Roberge, D., Norton, L., Bégin, L. R., et al. (2003) · Breast Cancer Research · doi:10.1186/bcr658 · Cited by 307
Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., & Sidransky, D. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1747 · Cited by 306
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
Jones, M. B., Krutzsch, H., Shu, H., Zhao, Y., Liotta, L. A., Kohn, E. C., & Petricoin, E. F. (2002) · PROTEOMICS · doi:10.1002/1615-9861(200201)2:1<76::aid-prot76>3.0.co;2-o · Cited by 290
Awai, K., Murao, K., Ozawa, A., Komi, M., Hayakawa, H., Hori, S., & Nishimura, Y. (2004) · Radiology · doi:10.1148/radiol.2302030049 · Cited by 272
Proteomics of human breast ductal carcinoma in situ.
Wulfkuhle, J. D., Sgroi, D. C., Krutzsch, H. C., McLean, K. C., McGarvey, K. M., Knowlton, M., Chen, S., Shu, H., Şahin, A. A., Kurek, R., et al. (2002) · PubMed · Cited by 256
Pharmacogenetics and cancer therapy
Relling, M. V., & Dervieux, T. (2001) · Nature Reviews Cancer · doi:10.1038/35101056 · Cited by 247
p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity
Wu, X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.9.681 · Cited by 245
Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
Califano, J. A., Westra, W. H., Meininger, G. R., Corio, R., Koch, W. M., & Sidransky, D. (2000) · PubMed · Cited by 242
Lossos, I. S., Alizadeh, A. A., Diehn, M., Warnke, R., Thorstenson, Y., Oefner, P. J., Brown, P. O., Botstein, D., & Levy, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.132253599 · Cited by 226
Press, M. F., Pike, M. C., Hung, G., et al. (1994) · PubMed · Cited by 222
DNA-microarray analysis of brain cancer: molecular classification for therapy
Mischel, P. S., Cloughesy, T. F., & Nelson, S. F. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1518 · Cited by 219
Sotiriou, C., Powles, T. J., Dowsett, M., Jazaeri, A. A., Feldman, A. L., Assersohn, L., Gadisetti, C., Libutti, S. K., & Liu, E. T. (2002) · Breast Cancer Research · doi:10.1186/bcr433 · Cited by 216
Nishizuka, S., Chen, S.-T., Gwadry, F. G., Alexander, J., Major, S. M., Scherf, U., Reinhold, W. C., Waltham, M. C., Charboneau, L., Young, L., et al. (2003) · PubMed · Cited by 202
Self-citationNew approaches to proteomic analysis of breast cancer
Wulfkuhle, J. D., McLean, K. C., Paweletz, C. P., Sgroi, D. C., Trock, B. J., Steeg, P. S., & Petricoin III, E. F. (2001) · PROTEOMICS · doi:10.1002/1615-9861(200110)1:10<1205::aid-prot1205>3.0.co;2-x · Cited by 198
Genome changes and gene expression in human solid tumors
Gray, J. W., & Collins, C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.443 · Cited by 193
Mitochondrial genome instability in human cancers
Bianchi, N. O., Bianchi, M. S., & Richard, S. M. (2001) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(00)00063-6 · Cited by 192
To, E. W. H., Chan, K. C. A., Leung, S. F., Chan, L. Y. S., To, K., Chan, A. T. �., Johnson, P. J., & Lo, Y. M. D. (2003) · PubMed · Cited by 189
Piekarz, R. L., Robey, R. W., Zhan, Z., Kayastha, G., Sayah, A., Abdeldaim, A. H., Torrico, S., & Bates, S. E. (2004) · Blood · doi:10.1182/blood-2003-09-3068 · Cited by 186
DNA methylation and cancer therapy: new developments and expectations
Esteller, M. (2005) · Current Opinion in Oncology · doi:10.1097/01.cco.0000147383.04709.10 · Cited by 183
Leong, P. P., Koch, W. M., Reed, A., Eisele, D., Sidransky, D., Jen, J., Rezai, B., Lee, D.-J., & Westra, W. H. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.13.972 · Cited by 175
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Piekarz, R., & Bates, S. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383980 · Cited by 174
Utility of Tumor Markers in Determining Resectability of Pancreatic Cancer
Schlieman, M. G. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.9.951 · Cited by 172
Kostakoğlu, L., & Goldsmith, S. J. (2003) · PubMed · Cited by 172
Leung, S., Chan, A. T. C., Zee, B., Ma, B., Chan, L. Y. S., Johnson, P. J., & Dennis Lo, Y. M. (2003) · Cancer · doi:10.1002/cncr.11496 · Cited by 161
Califano, J. A., Westra, W. H., Koch, W. M., Meininger, G., Reed, A., Yip, L., Boyle, J. O., Lonardo, F., & Sidransky, D. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.599 · Cited by 159
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
Hoon, D. S. �., Bostick, P. J., Kuo, C., Okamoto, T., Wang, H., Elashoff, R. M., & Morton, D. L. (2000) · PubMed · Cited by 145
Zou, T.-T., Selaru, F. M., Xu, Y. H., Shustova, V., Yin, J., Mori, Y., Shibata, D., Sato, F., Wang, S., Olaru, A., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205613 · Cited by 141
Agrawal, M., Abraham, J., Balis, F. M., Edgerly, M., Stein, W. D., Bates, S. E., Fojo, T., & Chen, C. C. (2003) · PubMed · Cited by 135
The promise of biomarkers in cancer screening and detection
Negm, R. S., Verma, M., & Srivastava, S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02353-5 · Cited by 126
Destounis, S. V., DiNitto, P. A., Logan-Young, W. W., Bonaccio, E., Zuley, M. L., & Willison, K. M. (2004) · Radiology · doi:10.1148/radiol.2322030034 · Cited by 124
Ramírez, J. L., Sarries, C., Castro, P., Roig, B., Queralt, C., Escuín, D., de Aguirre, I., Sánchez, J. M., Manzano, J. L., Vila, M. M., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00740-1 · Cited by 121
Janne, P. A., Li, C., Zhao, X., Girard, L., Chen, T.-H., Minna, J. D., Christiani, D. C., Johnson, B. E., & Meyerson, M. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207329 · Cited by 117
Seydel, C. (2003) · Science · doi:10.1126/science.300.5616.80 · Cited by 116
Molecular targeting with radionuclides: state of the science.
Britz-Cunningham, S. H., & Adelstein, S. J. (2003) · PubMed · Cited by 114
Gene-expression profiling in human cutaneous melanoma
Carr, K. M., Bittner, M. L., & Trent, J. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206448 · Cited by 113
Kahn, H. J., Presta, A., Yang, L., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000036897.92513.72 · Cited by 108
Verma, M., Wright, G. L., Hanash, S., Gopal-Srivastava, R., & Srivastava, S. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03870.x · Cited by 106
Alteration of mitochondrial DNA in human oncocytomas
Welter, C., Kovács, G., Seitz, G., & Blin, N. (1989) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870010112 · Cited by 93
Einspahr, J. G., Alberts, D. S., Gapstur, S. M., Bostick, R. M., Emerson, S. S., & Gerner, E. W. (1997) · PubMed · Cited by 85
Haplotype and Linkage Disequilibrium Architecture for Human Cancer-Associated GenesPreprint
Bonnen, P. E., Wang, P. J., Kimmel, M., Chakraborty, R., & Nelson, D. L. (2002) · Genome Research · doi:10.1101/gr.483802 · Cited by 84
Assessing the Use of p16INK4a Promoter Gene Methylation in Serum for Detection of Bladder Cancer
Valenzuela, M., Galisteo, R., Zuluaga, A., Villalobos, M., Núñez, M. I., Oliver, F. J., & de Almodóvar, J. M. R. (2002) · European Urology · doi:10.1016/s0302-2838(02)00468-2 · Cited by 82
Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients
Nakayama, H., Hibi, K., Takase, T., Yamazaki, T., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2003) · International Journal of Cancer · doi:10.1002/ijc.11117 · Cited by 78
Computer-Aided Detection and Diagnosis at the Start of the Third Millennium
Erickson, B. J., & Bartholmai, B. J. (2002) · Journal of Imaging Informatics in Medicine · doi:10.1007/s10278-002-0011-x · Cited by 66
Pharmacogenomics — Teaching Old Drugs New Tricks
Weinstein, J. N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431910 · Cited by 65
Self-citationHammond, M. E. H., & Taube, S. E. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.32896 · Cited by 64
'Omic' and hypothesis-driven research in the molecular pharmacology of cancer
Weinstein, J. N. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00185-6 · Cited by 63
Self-citationPolymorphisms in the CYP1A1 gene are associated with prostate cancer risk
Chang, B., Zheng, S. L., Isaacs, S. D., Turner, A. R., Hawkins, G. A., Wiley, K. E., Bleecker, E. R., Walsh, P. C., Meyers, D. A., Isaacs, W. B., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11249 · Cited by 62
Cancer Biomarker Validation: Standards and Process
Barker, P. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05969.x · Cited by 59
Yamaguchi, S., Asao, T., Nakamura, J.-I., Ide, M., & Kuwano, H. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00055-7 · Cited by 52
Automated Cervical Cytology: Meta-Analyses of the Performance of the PAPNET System
Abulafia, O., & Sherer, D. M. (1999) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199904000-00022 · Cited by 26
Research works printed but not linked: 27
- Sobin, L. H. TNM: evolution and relation to other prognostic factors. Semin. Surg. Oncol. 21, 3–7 (2003). Historical perspective of the TNM staging guidelines. · doi:10.1002/ssu.10014
- American Joint Committee on Cancer & American Cancer Society. AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual (eds Greene, F. L. et al.) (Springer, New York, 2002). AJCC guidelines for cancer staging.
- McQuade, P. & Knight, L. C. Radiopharmaceuticals for targeting the angiogenesis marker αvβ3 . Q. J. Nucl. Med. 47, 209–220 (2003).
- Kuge, Y. et al. Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model. J. Nucl. Med. 45, 309–312 (2004).
- Krohn, K. A. Evaluation of alternative approaches for imaging cellular growth. Q. J. Nucl. Med. 45, 174–178 (2001).
- Kaneda, H. et al. Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer. Lung Cancer 46, 247–254 (2004). · DOI
- Lenz, H. J. The use and development of germline polymorphisms in clinical oncology. J. Clin. Oncol. 22, 2519–2521 (2004). · doi:10.1200/jco.2004.04.900
- Stathopoulou, A. et al. Real-time quantification of CK-19 mrna-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clin. Cancer Res. 9, 5145–5151 (2003).
- Muller, V. & Pantel, K. Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives. Breast Cancer Res. 6, 258–261 (2004). · doi:10.1186/bcr942
- Best, C. J. et al. Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn. Mol. Pathol. 12, 63–70 (2003). · doi:10.1097/00019606-200306000-00001
- Service, R. F. American Chemical Society Meeting. Tiny transistors scout for cancer. Science 300, 242–243 (2003).
- Ben-Ari, E. T. Nanoscale quantum dots hold promise for cancer applications. J. Natl Cancer Inst. 95, 502–504 (2003). · doi:10.1093/jnci/95.7.502
- Patel, V., Leethanakul, C. & Gutkind, J. S. New approaches to the understanding of the molecular basis of oral cancer. Crit. Rev. Oral Biol. Med. 12, 55–63 (2001). · doi:10.1177/10454411010120010401
- Ornstein, D. K. et al. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines. Electrophoresis 21, 2235–2242 (2000). · doi:10.1002/1522-2683(20000601)21:11<2235::aid-elps2235>3.0.co;2-a
- Gutman, S. Regulatory issues in tumor marker development. Semin. Oncol. 29, 294–300 (2002). Examines the regulatory environment surrounding biomarker approval by the FDA and CMS. · doi:10.1053/sonc.2002.33140
- Taube, S. E. & Freiberg, G. P. Regulatory issues related to marker development. Urol. Oncol. 5, 214–216 (2000). · doi:10.1016/s1078-1439(00)00076-4
- Hackett, J. L. & Lesko, L. J. Microarray data — the US FDA, industry and academia. Nature Biotechnol. 21, 742–743 (2003). · doi:10.1038/nbt0703-742
- Mendelsohn, A. R. & Brent, R. Postgenomic protein analysis: the next bend in the river. Nature Biotechnol. 16, 520–521 (1998). · doi:10.1038/nbt0698-520
- Togashi, K. Ovarian cancer: the clinical role of US, CT, and MRI. Eur. Radiol. 13 (Suppl. 4), L87–L104 (2003). · doi:10.1007/s00330-003-1964-y
- Depres-Brummer, P. et al. The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer. J. Cancer Res. Clin. Oncol. 121, 419–422 (1995). · doi:10.1007/bf01212949
- Duncan, J. L., Price, A. & Rogers, K. The use of CA15.3 as a serum tumour marker in breast carcinoma. Eur. J. Surg. Oncol 17, 16–19 (1991).
- Gion, M. et al. Tumor markers in breast cancer monitoring should be scheduled according to initial stage and follow-up time: a prospective study on 859 patients. Cancer J. 7, 181–190 (2001).
- Lee, S. G. et al. Genetic polymorphisms of XRCC1 and risk of gastric cancer. Cancer Lett. 187, 53–60 (2002). · doi:10.1016/s0304-3835(02)00381-6
- Hoque, M. O., Lee, C. C., Cairns, P., Schoenberg, M. & Sidransky, D. Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis. Cancer Res. 63, 2216–2222 (2003).
- Mueller, N. Overview: viral agents and cancer. Environ. Health Perspect. 103 (Suppl. 8), 259–261 (1995).
- Pellet, C. et al. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J. Invest. Dermatol. 117, 858–863 (2001). · doi:10.1046/j.0022-202x.2001.01465.x
- Weinstein, J. N. Fishing expeditions. Science 282, 628–629 (1998). · doi:10.1126/science.282.5389.627g
Cited by
Gold Nanoparticles in Chemical and Biological Sensing
Saha, K., Agasti, S. S., Kim, C., Li, X., & Rotello, V. M. (2012) · Chemical Reviews · doi:10.1021/cr2001178 · Cited by 4,620
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Protein Analysis by Shotgun/Bottom-up Proteomics
Zhang, Y., Fonslow, B. R., Shan, B., Baek, M.-C., & Yates, J. R. (2013) · Chemical Reviews · doi:10.1021/cr3003533 · Cited by 1,491
Paul Ehrlich's magic bullet concept: 100 years of progress
Strebhardt, K., & Ullrich, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2394 · Cited by 1,457
Ardito, F., Giuliani, M., Perrone, D., Troiano, G., & Muzio, L. L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3036 · Cited by 1,336
Metadata
- Authors
- Ludwig, J. A., & Weinstein, J. N.
- Venue
- Nature Reviews Cancer
- Published
- 2005-10-20
- Volume
- 5
- Issue
- 11
- Pages
- 845-856
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2126415088
- Cited by
- 1,666
- References
- 118
- FWCI
- 2.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.